No results found for “”
No results found for filter “”
-
EFPIA News 27.02.26
Impact of Innovative Medicines/Health Initatives projects on rare diseases
Rare diseases present unique scientific, clinical and economic challenges, and through IMI and IHI public-private partnerships, Europe is building the...
Read Article -
Statements & press releases 26.02.26
Call to ‘Stop the Clock’ on UWWTD – Urgent reassessment needed to protect competitiveness and supply
Cost of cleaning Europe’s water set to be three to five times more than estimated by the European Commission, and mistakes occurred in the allocation of...
Read Article -
Statements & press releases 24.02.26
35,000 more patients to get access to clinical trials if new EU targets are met
New research from Frontier Economics, published today by EFPIA, shows that 35,000 Europeans will benefit from access to groundbreaking medical treatments...
Read Article -
EFPIA News 20.02.26
EFPIA response to the General Court ruling on the Urban Wastewater Treatment Directive
The General Court has dismissed EFPIA's action for annulment of the Urban Wastewater Treatment Directive (UWWTD) on the grounds of lack of legal standing. While...
Read Article -
EFPIA News 19.02.26
A comparative analysis of biopharmaceutical strategies in 10 countries
Biopharma is no longer just a health issue. It is a geopolitical and economic priority. In the global race for innovation, countries are investing in biotech...
Read Article -
Blog articles 19.02.26
The state of caregiving in the EU: Rising to the moment & delivering long-lasting change (Guest blog)...
Europe is entering a decisive decade for care. Across the EU, the demand for long-term care is rising sharply: by 2030, an estimated 23.6 million people...
Read Article -
Blog articles 13.02.26
Ensuring equal access to early cancer detection and treatment in Slovenia (Guest blog)
Slovenia marked World Cancer Day with its 6th Strategic Conference Living with Cancer, held at the National Council of the Republic of Slovenia - a venue...
Read Article -
Statements & press releases 09.02.26
Digital Medicines Information gains momentum
A new report from AESGP, EFPIA and Medicines for Europe provides a comprehensive overview of electronic Product Information (ePI) pilot projects across...
Read Article -
Statements & press releases 09.02.26
European pharmaceuticals key to strengthening EU competitiveness
Without the pharmaceutical industry the EU trade balance would go from a surplus of €147 billion to a €47 billion deficit
Read Article -
Blog articles 04.02.26
More people are living with cancer for longer – and more young people are surviving it (Guest blog)
Across Europe, cancer care has been undergoing a slow but steady revolution. While the number of people diagnosed with cancer continues to rise, mortality...
Read Article -
Statements & press releases 20.01.26
EFPIA Statement on the EU–Mercosur Free Trade Agreement
While the agreement includes some progress for the innovative pharmaceutical sector, particularly through partial tariff reductions, it could have gone further in...
Read Article -
Statements & press releases 20.01.26
EFPIA statement following European Parliament plenary vote on the Critical Medicines Act
EFPIA acknowledges today’s vote in the European Parliament plenary on the Critical Medicines Act (CMA).
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 27.02.26
Impact of Innovative Medicines/Health Initatives projects on rare diseases
Rare diseases present unique scientific, clinical and economic challenges, and through IMI and IHI public-private partnerships, Europe is building the...
Read Article -
EFPIA News 20.02.26
EFPIA response to the General Court ruling on the Urban Wastewater Treatment Directive
The General Court has dismissed EFPIA's action for annulment of the Urban Wastewater Treatment Directive (UWWTD) on the grounds of lack of legal standing. While...
Read Article -
EFPIA News 19.02.26
A comparative analysis of biopharmaceutical strategies in 10 countries
Biopharma is no longer just a health issue. It is a geopolitical and economic priority. In the global race for innovation, countries are investing in biotech...
Read Article -
EFPIA News 15.01.26
Safeguarding intellectual property and trade secrets in the European Health Data Space
EFPIA, MedTech Europe, EUCOPE and COCIR endorse DIGITALEUROPE’s paper “Safeguarding Intellectual Property and Trade Secrets in the European Health Data...
Read Article -
EFPIA News 10.12.25
Advancing Environmental Sustainability Assessment of Pharmaceuticals through Standardisation and Harmonisation...
EFPIA acknowledges the interest in having product environmental data to support climate goals, and member companies are proactively preparing to be able...
Read Article -
EFPIA News 09.12.25
AI Across the Medicines Lifecycle: Insights from Preliminary Case Studies and Considerations for Policy...
As AI becomes more deeply embedded in regulatory decision-making and processes that impact patients, the need for robust governance becomes critical.
Read Article -
EFPIA News 21.10.25
Don’t fall for dupes
Fake medicines are everywhere online, and they’re dangerous. Over 50% of medicines sold online are counterfeit. That’s why EFPIA and TikTok are teaming...
Read Article -
EFPIA News 25.09.25
A Blueprint for Action to address Obesity in the European Union
Obesity is among the most pressing public health challenges of this century and one that is posing a significant burden on Europe’s population and health...
Read Article -
EFPIA News 16.07.25
EFPIA submits GDPR Code of Conduct for formal assessment
EFPIA is pleased to announce the submission of its GDPR Code of Conduct on Clinical Trials and Pharmacovigilance to the Belgian Data Protection Authority...
Read Article -
EFPIA News 04.07.25
EFPIA Position on the Critical Medicines Act
By embedding flexibility, coordination, and proportionate regulation into its implementation, the Act can support a future-ready pharmaceutical ecosystem...
Read Article -
EFPIA News 11.06.25
EFPIA response to the European Commission call for evidence on the EU Biotech Act
To make the EU more attractive for researching, developing and manufacturing new technologies, we urge coordinated and urgent action across several areas. ...
Read Article -
EFPIA News 17.03.25
Harnessing RWE to transform healthcare decision-making in Europe
EFPIA vision on the role and use of RWE in decision-making
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 26.02.26
Call to ‘Stop the Clock’ on UWWTD – Urgent reassessment needed to protect competitiveness and supply
Cost of cleaning Europe’s water set to be three to five times more than estimated by the European Commission, and mistakes occurred in the allocation of...
Read Article -
Statements & press releases 24.02.26
35,000 more patients to get access to clinical trials if new EU targets are met
New research from Frontier Economics, published today by EFPIA, shows that 35,000 Europeans will benefit from access to groundbreaking medical treatments...
Read Article -
Statements & press releases 09.02.26
Digital Medicines Information gains momentum
A new report from AESGP, EFPIA and Medicines for Europe provides a comprehensive overview of electronic Product Information (ePI) pilot projects across...
Read Article -
Statements & press releases 09.02.26
European pharmaceuticals key to strengthening EU competitiveness
Without the pharmaceutical industry the EU trade balance would go from a surplus of €147 billion to a €47 billion deficit
Read Article -
Statements & press releases 20.01.26
EFPIA Statement on the EU–Mercosur Free Trade Agreement
While the agreement includes some progress for the innovative pharmaceutical sector, particularly through partial tariff reductions, it could have gone further in...
Read Article -
Statements & press releases 20.01.26
EFPIA statement following European Parliament plenary vote on the Critical Medicines Act
EFPIA acknowledges today’s vote in the European Parliament plenary on the Critical Medicines Act (CMA).
Read Article -
Statements & press releases 16.12.25
EFPIA response to SANT Committee vote on the Critical Medicines Act: Important step although certain...
Europe needs a CMA that works rather than one that tries to address everything.
Read Article -
Statements & press releases 16.12.25
EFPIA and Vaccines Europe back the EU Safe Hearts Plan to improve cardiovascular health and call for...
With one in three deaths in the EU linked to cardiovascular disease and 13 million new diagnoses each year, swift implementation of the Plan is now essential. ...
Read Article -
Statements & press releases 16.12.25
EFPIA and Vaccines Europe see Biotech Act and revision of the MDR/IVDR as a positive signal for European...
As global competition for life science investment intensifies, the health package published today by the European Commission is a positive step toward...
Read Article -
Statements & press releases 11.12.25
EFPIA response to pharmaceutical package agreement: More to do to keep European pharma competitive
While the package contains signals that the EU recognises the importance of the legislation as a key driver of competitiveness for the innovative pharmaceutical...
Read Article -
Statements & press releases 10.12.25
Environmental omnibus to deliver EU simplification agenda fails to address unworkable UWWTD
EFPIA reiterates its call for the suspension of Articles 9 and 10 and Annex III of the UWWTD pending a proper assessment of impacts, alongside urgently...
Read Article -
Statements & press releases 05.12.25
EFPIA calls for a balanced approach to Economic Security that builds on the strength of Europe’s innovative...
The research-based pharmaceutical sector is a critical strategic security asset and the highest contributor to the EU trade surplus, supporting 2.3 million...
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 19.02.26
The state of caregiving in the EU: Rising to the moment & delivering long-lasting change (Guest blog)...
Europe is entering a decisive decade for care. Across the EU, the demand for long-term care is rising sharply: by 2030, an estimated 23.6 million people...
Read Article -
Blog articles 13.02.26
Ensuring equal access to early cancer detection and treatment in Slovenia (Guest blog)
Slovenia marked World Cancer Day with its 6th Strategic Conference Living with Cancer, held at the National Council of the Republic of Slovenia - a venue...
Read Article -
Blog articles 04.02.26
More people are living with cancer for longer – and more young people are surviving it (Guest blog)
Across Europe, cancer care has been undergoing a slow but steady revolution. While the number of people diagnosed with cancer continues to rise, mortality...
Read Article -
Blog articles 20.01.26
From readiness to reality: preparing Europe for the next phase of Alzheimer’s care (Guest blog)
Europe has reached a turning point on Alzheimer’s disease, where scientific breakthroughs are no longer theoretical, but demand urgent action to turn innovation...
Read Article -
Blog articles 17.12.25
National Cancer Plans: Turning ambition into impact (Guest blog)
Plans are only as good as their tangible impact on patients and healthcare systems. Europe’s Beating Cancer Plan brought real momentum to the fight against...
Read Article -
Blog articles 04.12.25
Harmonizing health: Impact of international regulatory organisations on pharmaceutical regulatory activities...
Global alignment is essential for timely access to innovation. This piece explores how ICH and other international organisations strengthen regulatory...
Read Article -
Blog articles 02.12.25
Slovenia can become a European leader in Cancer Care: Insights from Dr. Thomas Hofmarcher (Guest blog)...
At the 2025 Tribuna of Hope, one of Slovenia’s most prominent annual gatherings of patient associations, oncology experts, and public figures, Dr. Thomas...
Read Article -
Blog articles 18.11.25
The Unseen Arsenal: Why health is the new economic battleground (Guest blog)
As geopolitical tensions intensify, a nation’s true strength may lie in its ability to invest in human capital and ensure the health and prosperity of...
Read Article -
Blog articles 04.11.25
From guidance to implementation: EFPIA’s reflections on EU HTA scoping & PICO exercises
As the EU launches its first JCA, EFPIA shares reflections on the new HTA scoping guidance and PICO exercises
Read Article -
Blog articles 04.11.25
How can companies manage reputational risks in a changing world?
From fraud and cybercrime to compliance and data protection, life sciences firms must monitor risks to avoid being blindsided – here are 5 steps to better...
Read Article -
Blog articles 29.10.25
Clinical trials: Swift EU reforms could make 2026 a turning point
Building on positive momentum, it’s time to implement centralisation and deliver shorter approval times
Read Article -
Blog articles 02.10.25
From half measures to full ambition: building a world-class regulatory framework (Guest blog)
Europe’s pharma reform is an opportunity to strengthen resilience, speed up access to medicines, and secure our place in global health innovation.
Read Article